Prevalence of blood-borne viral hepatitis in different communities in Yemen

Epidemiology and Infection

Volumn 131, Issue 1, 2003, Pages 771-775

  Sallam, T A ^a   Tong, C Y W ^b   Cuevas, L E ^c   Raja'a, Y A ^a   Othman, A M ^d   Al Kharsa, K R ^a  

^a SANA A UNIVERSITY   (Yemen)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d Department of Microbiology   (Yemen)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD DONOR; COMMUNITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CARRIER; DISEASE MARKER; DISEASE PREDISPOSITION; ETHNIC GROUP; FEMALE; GEOGRAPHY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLITICS; PREVALENCE; SEX DIFFERENCE; SOCIAL STATUS; VIRUS HEPATITIS; VIRUS INFECTIVITY; YEMEN;

ADOLESCENT; ADULT; BLOOD DONORS; FEMALE; GEOGRAPHY; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; POLITICS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; SOCIAL CONDITIONS; YEMEN;

EID: 0042856316     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268803008653     Document Type: Article

References (15)

1. Kane M. Global status of hepatitis B immunization. Lancet 1996; 348: 696.
2. Laure GM, Waker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
3. Margolis HS, Alter MJ, Hadler SC. Viral hepatitis. In: Evans AS, Kaslow RA, eds. Viral Infections of Humans. New York: Plenum Publishing Corporation, 1997: 363-418.
4. André F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18 (Suppl): S20-S22.
5. Frank C, Mohamed MK, Strickland GT, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-891.
6. Al-Bahrani A, Panhotra BR. Prevalence of HBsAg and anti HCV antibodies in blood donors of the Al-Hasa region of the Saudi Arabia. Ann Saudi Med 2001; 21: 234-235.
7. Othman BA, Monem FS. Prevalence of hepatitis C antibodies among intravenous drug abusers and prostitutes in Damascus, Syria. Saudi Med J 2002; 23: 393-395.
8. Scott DA, Burans JP, Al-Ouzeib HD, et al. A sero-epidemiologcal survey of viral hepatitis in Yemen Arab Republic. Trans R Soc Trop Med Hyg 1990; 2: 288-291.
9. Scott DA, Constantine NT, Callahan J, et al. The epidemiology of hepatitis C virus antibody in Yemen. Am J Trop Med Hyg 1992; 46: 63-68.
10. Al-Robasi AA, Al-Harbi L. Prevalence of markers for human immunodeficiency virus (HIV-1), hepatitis B and syphilis among blood donors in Yemen. Yemeni Med J 1996; 2: 58-60.
11. Sallam TA, Tong CYW. Two distinct types of hepatitis B virus core promoter variants in Yemeni blood donors. J Med Virol 2002; 68: 328-334.
12. Abdel Raheem SM, Abou-Lohum TS, el-Didy H, el-Eriani H, Mansour S, Hafez AS. Hepatitis B infection in Sana'a city, Republic of Yemen. Prevalence among pregnant women and materno-foetal transmission. J Egyptian Public Health Assoc 1991; 66: 491-503.
13. Al-Nassiri KA, Raja'a YA. Hepatitis B virus infection in Yemenis of Sana'a: pattern and risk factors. Eastern Medit Health J 2001; 7: 147-152.
14. Denis F, Aussel L, Ranger S, et al. Prevalence of antibodies to hepatitis C virus among patients with leprosy in several African countries and the Yemen. J Med Virol 1994; 43: 1-4.
15. Irving W. The role of the virology laboratory in the management of hepatitis C virus infection. J Clin Virol 2002; 25: 3-13.